iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding iTeos Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 146 | 2 | 144 | 0 |
| Shares | 34.8M | 147.0K | 35.5M | +866.2K (+2.5%) |
| Value | $460.4M | $1.95M | $388.6M | −$69.9M (−15.2%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 723,000 | $7.92M | 0.17% |
| Janus Henderson Group PLC | 500,324 | $5.48M | 0.00% |
| Ikarian Capital, LLC | 346,471 | $3.79M | 1.41% |
| Y-Intercept (Hong Kong) Ltd | 26,435 | $289.5K | 0.03% |
| Squarepoint Ops LLC | 25,208 | $276.0K | 0.00% |
| Adage Capital Partners GP, L.L.C. | 20,000 | $219.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 13,077 | $143.2K | 0.00% |
| HSBC Holdings PLC | 13,070 | $142.6K | 0.00% |
| CI Private Wealth, LLC | 12,889 | $141.1K | 0.00% |
| Syon Capital LLC | 12,368 | $135.4K | 0.02% |
| Comerica Bank | 12,243 | $134.1K | 0.00% |
| Quantbot Technologies LP | 4,700 | $51.5K | 0.00% |
| Point72 Middle East FZE | 2,239 | $24.5K | 0.00% |
| Point72 Asset Management, L.P. | 921 | $10.1K | 0.00% |
| Fifth Third Bancorp | 188 | $2.06K | 0.00% |
Sold out (15)
Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of Montreal | 171,389 | $3.10M |
| AlphaCentric Advisors LLC | 63,000 | $834.1K |
| Marshall Wace, LLP | 35,429 | $469.1K |
| ClariVest Asset Management LLC | 35,255 | $467.0K |
| Qube Research & Technologies Ltd | 16,413 | $217.3K |
| Franklin Resources Inc | 12,072 | $159.8K |
| Simplex Trading, LLC | 11,503 | $152.0K |
| Worth Venture Partners, LLC | 10,900 | $144.3K |
| Group One Trading, L.P. | 7,321 | $96.9K |
| C M Bidwell & Associates Ltd | 3,929 | $52.0K |
| KBC Group NV | 1,773 | $23.0K |
| Aquatic Capital Management LLC | 1,400 | $19.0K |
| Parallel Advisors, LLC | 227 | $3.00K |
| Massmutual Trust Co FSB | 162 | $2.15K |
| 25 LLC | 34 | $473 |
Not filed for Q3 2023 yet (2)
Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EA Series Trust | 101,304 | $1.34M |
| Tekla Capital Management LLC | 45,735 | $605.5K |